StockData
Flyte Aviation, Inc. logo

Flyte Aviation, Inc. (VJET) company profile

VJETNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3087% below fair value
$0.44−0.05 (-10.11%)

Close on Nov 16, 2026Market cap $6.38MP/E –Yield –

About Flyte Aviation

Surgical & Medical Instruments & Apparatus, SIC 3841

Catheter Precision, Inc. designs, manufactures, and markets medical technologies focused on cardiac electrophysiology, with an emphasis on the catheter ablation market. Its primary product is the VIVO System, a non-invasive imaging platform that utilizes three-dimensional cardiac mapping to localize the origin of ventricular arrhythmias prior to electrophysiology procedures. The company also produces LockeT, a sterile suture retention device engineered to aid wound healing, temporarily secure sutures, and promote hemostasis following catheterization. Additionally, the company operates a private aviation charter business called FLYTE. Catheter Precision primarily serves hospitals that operate cardiac electrophysiology laboratories.

The company markets its products domestically through direct sales personnel and internationally via third-party distributors. The VIVO system has been utilized across eleven countries, including clinical use and placements in the United States, the United Kingdom, and the European Union. Assembly, inventory management, and product fulfillment for VIVO take place in an approximate 2,000-square-foot facility situated in Fort Mill, South Carolina.

Summary of the business section of Flyte Aviation's latest annual report, written by StockData.

Company profile

Company

Legal name
Flyte Aviation, Inc.
Founded
2018
Headquarters
Fort Mill, SC
Address
1670 Highway 160 West, Suite 205 29708
Phone
(973) 691-2000
Employees
17, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
WithumSmith+Brown, PC, East Brunswick, New Jersey

Stock & identifiers

Ticker
VJET
Former tickers
RMED until Oct 5, 2026
Exchange
NYSE
IPO date
Sep 27, 2018
Shares outstanding
14M, Aug 10, 2026
Public float
$3.90M, Jun 30, 2024
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-10 reverse, Oct 5, 2026; 1-for-19 reverse, Aug 15, 2025; 1-for-10 reverse, Jul 15, 2024; 1-for-50 reverse, Oct 3, 2022; 1-for-25 reverse, Nov 17, 2020
SEC CIK
1716621
FIGI
BBG0029BD0V2
Share class FIGI
BBG0029BD0W1
EIN
38-3661826

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
David A. JenkinsChairman of the Board and CEO, Director48,487
Philip J. AndersonChief Financial Officer0
Marie-Claude JacquesChief Commercial Officer0
Andrew ArnoDirector0
Martin J. ColombattoDirector57
James Joseph CarusoDirector50

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2024–$0$287.92K$-0–
FY2024
Mr Jenkins
$300.00K$300.00K$287.92K$-0–
FY2024
Mr Mc Guire
$0$300.00K$287.92K$-0–
FY2023
Mr Jenkins
$300.00K$300.00K$189.66K$1–
FY2023
Mr Mc Guire
$1.92M$1.92M$189.66K$1–
FY2022$0$0$234.88K$8–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryOption awardsTotalvs. prior year
David A. Jenkins
Executive Chairman and CEO
$300.00K$219.25K$519.25K+73%
Philip Anderson
CFO
$197.82K$208.45K$406.27K–
Margrit Thomassen
Former Interim CFO (1)
$150.00K$23.78K$173.78K–
Marie-Claude Jacques
Former CCO (2)
$200.00K$41.75K$241.75K-39%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Sep 27, 2018
Offer price
$17.00
Securities offered
3,900,000
Gross proceeds
$66.30M
Exchange
NYSE
First trading day
Sep 27, 2018
First-day close
$20.00+17.7%
Lock-up ends (est.)
Mar 26, 2019

“The initial public offering price is $17.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of March 18, 2026, we had a total of 17 employees, including 17 full-time employees, which include finance and administrative, research and development, sales and marketing and clinical professionals.”

Corporate history

Events identified from SEC filings

DateEventDetails
Oct 2, 2026Name changeName changed from Catheter Precision, Inc. to Flyte Aviation, Inc.
May 18, 2026Late filingNotification of late filing
May 13, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 8, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 23, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 15, 2023Late filingNotification of late filing
Aug 25, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 15, 2023Name changeName changed from Ra Medical Systems, Inc. to Catheter Precision, Inc.
Aug 15, 2023Late filingNotification of late filing
Jun 26, 2023Auditor changeChange in certifying accountant (8-K Item 4.01)
May 30, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 16, 2023Late filingNotification of late filing
Mar 29, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jan 19, 2023Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 13, 2023Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Sep 2, 2022Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Apr 8, 2021Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 29, 2021DelistingNotice of delisting from exchange (Form 25)
Dec 17, 2020Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Dec 17, 2020ListingRegistration of securities on an exchange (Form 8-A)
May 22, 2020Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Dec 6, 2019Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Nov 15, 2019Late filingNotification of late filing
Aug 23, 2019Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 15, 2019Late filingNotification of late filing
Sep 27, 2018IPOInitial public offering priced (424B4 prospectus)
Sep 26, 2018ListingRegistration of securities on an exchange (Form 8-A)

See a number that looks wrong?